Health care expenditures for Medicaid-covered males with haemophilia in the United States, 2008

Haemophilia

Volumn 18, Issue 2, 2012, Pages 276-283

  Guh, S ^a   Grosse, S D ^a   McAlister, S ^a   Kessler, C M ^b   Soucie, J M ^a  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Claims data; Cost of care; Employer sponsored insurance; Health care utilization; Inhibitor; Medicaid

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DISABILITY; HEALTH CARE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HEMOPHILIA; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICARE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PUBLIC HEALTH INSURANCE; SCHOOL CHILD; UNITED STATES;

ADOLESCENT; ADULT; AGED; BLOOD COAGULATION FACTORS; CHILD; CHILD, PRESCHOOL; HEALTH EXPENDITURES; HEALTH SERVICES; HEMOPHILIA A; HEPATITIS C; HIV INFECTIONS; HUMANS; INFANT; INSURANCE, HEALTH; MALE; MEDICAID; UNITED STATES; YOUNG ADULT;

EID: 84857112623     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2011.02713.x     Document Type: Article

References (13)

1. Soucie JM, Nuss R, Evatt B et al. Mortality among males with hemophilia: relations with source of medical care. Blood 2000; 96: 437-42.
2. Bohn RL, Aledort LM, Putnam KG et al. The economic impact of factor VIII inhibitors in patients with haemophilia. Haemophilia 2004; 10: 63-8.
3. Baker JR, Riske B, Voutsis M, Cutter S, Preslet P. Effect of insurance on hometherapy and prophylaxis among youth in the United States with severe hemophilia. Unpublished manuscript. 2011.
4. Healthcare Cost and Utilization Project (HCUP) database. Agency for Healthcare Research and Quality. Available at: Accessed 15 March 2011.
5. Medical Expenditure Panel Survey [online]. Available at: Accessed 14 July 2011.
6. Guh S, Grosse SD, McAlister S, Kessler CM, Soucie JM. Healthcare expenditures for males with haemophilia and employer-sponsored insurance in the United States, 2008. Haemophilia 2011; DOI: 10.1111/j.1365-2516.2011.02692.x.
7. Centers for Medicare & Medicaid Service. Medicaid eligibility [online]. Available at: & PageID=14259. Accessed 14 July 2011.
8. U.S. Social Security Administration. Disability Evaluation Under Social Security. Baltimore, MD: Social Security Administration. 2008. SSA Pub. No. 64-039, ICN 468600. Available at: Accessed 14 July 2011.
9. Tencer T, Friedman HS, Li-McLeod J, Johnson K. Medical costs and resource utilization for hemophilia patients with and without HIV or HCV infection. J Manag Care Pharm 2007; 13: 790-8.
10. Shatin D, Levin R, Ireys HT et al. Health care utilization by children with chronic illnesses: a comparison of Medicaid and employer-insured managed care. Pediatrics 1998; 102: e44.
11. Kuhlthau K, Ferris TG, Beal AC et al. Who cares for Medicaid-enrolled children with chronic conditions?. Pediatrics 2001; 108: 906-12.
12. Sorlie PD, Johnson NJ, Backlund E, Bradham DD. Mortality in the uninsured compared with that in persons with public and private health insurance. Arch Intern Med 1994; 154: 2409-16.
13. Mvundra M, Amenda D, Kavanagh PL, Sprinz PG, Grosse SD. Health care utilization and expenditures for privately and publicly insured children with sickle cell disease in the United States. Pediatr Blood Cancer 2009; 53: 642-6.